Gram-negative resistance: Can we combat the coming of a new "Red Plague"?

Medical Journal of Australia

Volumn 198, Issue 5, 2013, Pages 243-244

  Looke, David F M ^a   Gottlieb, Thomas ^b   Jones, Cheryl A ^c   Paterson, David L ^d  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; METALLO BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AUSTRALIA; BACTERIAL INFECTION; EDITORIAL; GOVERNMENT; GRAM NEGATIVE BACTERIUM; HEALTH CARE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; NONHUMAN; PUBLIC HEALTH; VETERINARY MEDICINE; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; AUSTRALIA; COMMUNICABLE DISEASE CONTROL; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; NEEDS ASSESSMENT; PUBLIC HEALTH; RISK FACTORS;

EID: 84876754217     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.10190     Document Type: Editorial

References (9)

1. Camus A. The plague (Fr. La Peste) Part 1. Librairie Gallimard, 1947.
2. Hawser SP, Bouchillon SK, Hoban DJ, et al. Emergence of high levels of extendedspectrum- lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 2009; 53: 3280-3284.
3. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11: 355-362.
4. Turnidge J, Gottlieb T, Mitchell D, et al; Australian Group on Antimicrobial Resistance. Gram-negative survey: community-onset infections 2010 - antimicrobial susceptibility report. Perth: AGAR, 2012. http://www.agargroup.org/files/AGAR%20GNB10%20REAL%20FINAL.pdf (accessed Feb 2013).
5. Sidjabat H, Nimmo GR, Walsh TR, et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo lactamase. Clin Infect Dis 2011; 52: 481-484.
6. Coatsworth NR, Huntington PG, Hardiman RP, et al. A case of carbapenemaseproducing Klebsiella pneumoniae in Australia. Pathology 2012; 44: 42-44.
7. Sidjabat HE, Derrington P, Nimmo GR, Paterson DL. Escherichia coli ST131 producing CTX-M-15 in Australia. J Antimicrob Chemother 2010; 65: 1301-1303.
8. Sidjabat HE, Kennedy K, Silvey A, et al. Emergence of blaOXA-181-carrying ColE plasmid in Klebsiella pneumoniae in Australia. Int J Antimicrob Agents 2013; 41: 294-296.
9. Fernando GATP, Collignon PJ, Bell JM. A risk for returned travellers: the "postantibiotic era" [letter]. Med J Aust 2010; 193: 59.